NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299,770 | +4.8% | 2,943 | 0.0% | 0.14% | +3.7% |
| Q2 2023 | $285,938 | +5.6% | 2,943 | 0.0% | 0.14% | +0.7% |
| Q1 2023 | $270,752 | +1.4% | 2,943 | 0.0% | 0.13% | -2.9% |
| Q4 2022 | $266,954 | +16.1% | 2,943 | -2.5% | 0.14% | +5.3% |
| Q3 2022 | $230,000 | -9.8% | 3,020 | 0.0% | 0.13% | -5.8% |
| Q2 2022 | $255,000 | -5.2% | 3,020 | -1.5% | 0.14% | +7.8% |
| Q1 2022 | $269,000 | +0.4% | 3,067 | +0.0% | 0.13% | +9.3% |
| Q4 2021 | $268,000 | +7.2% | 3,066 | +0.3% | 0.12% | +4.4% |
| Q3 2021 | $250,000 | -10.1% | 3,058 | +0.4% | 0.11% | -1.7% |
| Q2 2021 | $278,000 | -3.5% | 3,045 | 0.0% | 0.12% | -18.4% |
| Q4 2020 | $288,000 | +8.7% | 3,045 | +0.1% | 0.14% | -13.0% |
| Q3 2020 | $265,000 | – | 3,043 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |